Overview
Keratoconus is a progressive eye disorder in which the normally round cornea (the clear, dome-shaped front surface of the eye) thins and begins to bulge outward into a cone shape. This abnormal curvature changes the way light enters the eye, causing distorted and blurred vision that cannot be fully corrected with standard eyeglasses. Keratoconus typically begins during puberty or the late teenage years and may progress through the twenties and thirties before stabilizing. It usually affects both eyes, though often asymmetrically. Key symptoms include progressive nearsightedness (myopia), irregular astigmatism, increased light sensitivity (photophobia), glare, and frequent changes in eyeglass prescriptions. In advanced cases, corneal scarring may develop, further impairing vision. Some patients experience episodes of acute corneal hydrops, where fluid suddenly enters the cornea causing pain and a sudden decrease in vision. Note: This Orphanet entry (ORPHA:156071) is classified as OBSOLETE, meaning it may have been reclassified, merged, or reorganized within the Orphanet nomenclature. Keratoconus itself remains a well-recognized clinical entity. Treatment options range from rigid gas-permeable contact lenses and specialty scleral lenses in mild-to-moderate cases, to corneal collagen cross-linking (CXL) to slow or halt disease progression, and corneal transplantation (penetrating or deep anterior lamellar keratoplasty) in advanced cases. Intracorneal ring segments (such as Intacs) may also be used to improve corneal shape. The etiology is considered multifactorial, involving both genetic susceptibility and environmental factors such as chronic eye rubbing and atopic disease.
Multifactorial
Caused by a mix of several genes and environmental factors
Juvenile
Begins in the teen years
Treatments
1 availablePhotrexa Viscous
Indicated for use in corneal collagen crosslinking in combination with the KXL System for the treatment of progressive keratoconus
Clinical Trials
View all trials with filters →No actively recruiting trials found for OBSOLETE: Keratoconus at this time.
New trials open frequently. Follow this disease to get notified.
Specialists
View all specialists →No specialists are currently listed for OBSOLETE: Keratoconus.
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to OBSOLETE: Keratoconus.
Community
No community posts yet. Be the first to share your experience with OBSOLETE: Keratoconus.
Start the conversation →Latest news about OBSOLETE: Keratoconus
No recent news articles for OBSOLETE: Keratoconus.
Follow this condition to be notified when news becomes available.
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Common questions about OBSOLETE: Keratoconus
What is OBSOLETE: Keratoconus?
Keratoconus is a progressive eye disorder in which the normally round cornea (the clear, dome-shaped front surface of the eye) thins and begins to bulge outward into a cone shape. This abnormal curvature changes the way light enters the eye, causing distorted and blurred vision that cannot be fully corrected with standard eyeglasses. Keratoconus typically begins during puberty or the late teenage years and may progress through the twenties and thirties before stabilizing. It usually affects both eyes, though often asymmetrically. Key symptoms include progressive nearsightedness (myopia), irre
How is OBSOLETE: Keratoconus inherited?
OBSOLETE: Keratoconus follows a multifactorial inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.
At what age does OBSOLETE: Keratoconus typically begin?
Typical onset of OBSOLETE: Keratoconus is juvenile. Age of onset can vary across affected individuals.
What treatment and support options exist for OBSOLETE: Keratoconus?
1 patient support program are currently tracked on UniteRare for OBSOLETE: Keratoconus. See the treatments and support programs sections for copay assistance, eligibility, and contact details.